86895-0
Adalimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay
Active
Term Description
This term was created for, but not limited in use to, the submitter's Theradiag Lisa-Tracker Adalimumab and anti-Adalimumab test kits.
Part Descriptions
LP173592-9 Adalimumab
Adalimumab is a human monoclonal antibody that binds tumor necrosis factor alpha (TNFα). TNFα is a cell signaling protein that, when present in excess, may lead to the development of inflammatory immune diseases including Crohn's disease, rheumatoid arthritis, psoriatic arthritis and inflammatory bowel disease. Adalimumab inactivates TNFα by binding to the TNFα receptor. PMID: 23943614 Treatment with adalimumab does not necessitate laboratory monitoring though association with increased transamines and pancytopenia may argue for intermittant blood cell counts and liver function tests. Adalimumab has been associated with serious infections including the reactivation of tuberculosis and deep fungal infections as well as other rare side effects, including lymphoma, heart failure and demyelinating disease. PMID: 16011443
Source: Regenstrief LOINC
LP173593-7 Adalimumab Ab
Antibodies to adalimumab were shown to develop in 67% of patients within the first 28 weeks of treatment. Only thirteen percent of patients with adalimumab antibodies experienced relief from symptoms compared to 48% of patients without antibodies to adalimumab. Only 4% of patients with antibodies went into remission compared to 34% of patients who achieved remission without anti-adalimumab antibodies. Antibodies to adalimumab reduced the likelihood that patients would have relief from disease symptoms or go into remission. PMID: 21486979
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Adalimumab Ab
- Property
- MCnc
- Time
- Pt
- System
- Ser/Plas
- Scale
- Qn
- Method
- IA
Additional Names
- Long Common Name
- Adalimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay
- Short Name
- Adalimumab Ab SerPl IA-mCnc
- Display Name
- Adalimumab Ab IA [Mass/Vol]
- Consumer Name Alpha Get Info
- Adalimumab antibody, Blood
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.63
- Last Updated
- Version 2.63 (ADD)
- Order vs. Observation
- Both
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG28981-5 | Adalimumab Ab| |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
el-GR | Greek (Greece) | Αδαλιμουμάμπη Αντίσωμα: Synonyms: MCnc Αδαλιμουμάμπη |
es-ES | Spanish (Spain) | Adalimumab Anticuerpos: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Adalimumab Ab: |
fr-FR | French (France) | Adalimumab anticorps: |
it-IT | Italian (Italy) | Adalimumab Ab: Synonyms: anticorpo Concentrazione di Massa Immunoassay Livelli farmacologici e tossicologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma |
nl-NL | Dutch (Netherlands) | adalimumab As: Synonyms: antistof; |
ru-RU | Russian (Russian Federation) | Адалимумаб Ат: Synonyms: Антитело Количественный Массовая концентрация Плазма Сыворотка Сыворотка или Плазма Точка во времени; |
tr-TR | Turkish (Turkey) | Adalimumab Ab: Synonyms: İmmünölçüm, immünoassay |
zh-CN | Chinese (China) | 阿达木单抗 抗体: Synonyms: Ab; |
Example Units
Unit | Source |
---|---|
ng/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=86895-0
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://